Last reviewed · How we verify
NCT03251898
Correlation Between Premature Rupture of Membranes and Early-onset Neonatal Infections
trial in Premature Rupture of Membrane in 15,926 participants. Completed in 30 April 2018.
31 March 2018
Quick facts
| Lead sponsor | Bayi Children's Hospital Affiliated to PLA Army General Hospital, China |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 15,926 |
| Start date | 15 August 2017 |
| Primary completion | 31 March 2018 |
| Estimated completion | 30 April 2018 |
| Sites | 6 locations across China |
Conditions studied
- Premature Rupture of Membrane — all drugs for Premature Rupture of Membrane →
- Neonatal Infection — all drugs for Neonatal Infection →
Sponsor
Bayi Children's Hospital Affiliated to PLA Army General Hospital, China
Who can join
Eligibility, female only, with Premature Rupture of Membrane or Neonatal Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study hypothesizes that early-onset neonatal Infections are related to premature rupture of membrane (PROM) and that early intervention can improve the prognosis of newborns. The objective of this study is to analyze the correlation between PROM and early-onset neonatal infections and to assess the prognosis of newborns. A cohort study is designed to implement the study. The subjects of study group are pregnant women who are diagnosed as PROM or chorioamnionitis and whose gestational age is ≥ 24 weeks. The subjects of control group are pregnant women without PROM and chorioamnionitis. Control group and research group are paired at 1: 1 ratio. The main contents of the study include three aspects. (1) The correlation between PROM and chorioamnionitis. (2) The correlation between PROM and early-onset neonatal infections. (3) The pathogenesis of intrauterine infection and neonatal infection.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
The correlation between prelabour rupture of the membranes and neonatal infectious diseases, and the evaluation of guideline implementation in China: a multi-centre prospective cohort study.
Zhuang L, Li ZK, Zhu YF, Ju R, et al · · 2020 · cited 19× · PMID 34327382 · DOI 10.1016/j.lanwpc.2020.100029 -
Latency period of PROM at term and the risk of neonatal infectious diseases.
Zhuang L, Li ZK, Zhu YF, Ju R, et al · · 2022 · cited 7× · PMID 35851306 · DOI 10.1038/s41598-022-16593-6 -
Predicting risk of severe neonatal outcomes in preterm infants born from mother with prelabor rupture of membranes.
Zhuang L, Li ZK, Zhu YF, Ju R, et al · · 2022 · PMID 35787798 · DOI 10.1186/s12884-022-04855-0
Verify or expand the search:
- PubMed search for NCT03251898
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Premature Rupture of Membrane
Currently open trials in the same condition.
- NCT06273891 — Erythromycin Versus Azithromycin for Preterm Prelabor Rupture of Membranes · Phase 3 · recruiting
- NCT04451109 — Dilapan-S®: A Multicenter US E-registry · active not recruiting
Other Bayi Children's Hospital Affiliated to PLA Army General Hospital, China trials
Trials by the same sponsor.
- NCT04385134 — Enterovirus Surveillance During the Perinatal Period · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03251898 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bayi Children's Hospital Affiliated to PLA Army General Hospital, China
- Last refreshed: 27 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03251898.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing